These cytokines upregulated EGR1 expression in hepatocytes, adipocytes and skeletal myocytes to transcriptionally activate its downstream targets LCN2 and SOCS3, thus aggravating insulin resistance in SH. Here, EGR1 is linked to Insulin resistance.